hematology

reshuffle pipeline target reorganize shift change
Biotech

Novartis nixes 6 ph. 1 assets, adds 2 new cancer candidates

The Swiss pharma has scrapped four solid tumor assets and two hematology candidates in a shakeup of its early-stage pipeline.
Darren Incorvaia Feb 4, 2026 12:09pm
Stars twinkling in the night sky

ASH: Star antibody sparkles in preview of possible ph. 3 success

Dec 7, 2025 9:40am
Graphic of a drop of blood made up of small data points and nodes

Roche's Flatiron Health debuts 6 new blood cancer data sets

Oct 29, 2025 9:00am
blood test money

ASH launches $12M fund for scientists who lose federal grants

Jun 10, 2025 4:32pm
rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm
Graphic of a drop of blood made up of small data points and nodes

Takeda's $300M bet on Protagonist's blood cancer drug pays off

Mar 3, 2025 8:45am